Literature DB >> 10601270

Multiple modes of repression by the Smad transcriptional corepressor TGIF.

D Wotton1, R S Lo, L A Swaby, J Massagué.   

Abstract

TGIF is a DNA-binding homeodomain protein that has been demonstrated to play a role in transforming growth factor beta-regulated transcription and implicated in the control of retinoid-responsive transcription. We investigated the intrinsic transcriptional activity of TGIF fused to a heterologous DNA-binding domain. Our results demonstrate that TGIF is a transcriptional repressor able to repress transcription from several different promoters. Repression by TGIF is insensitive to the distance at which it is bound from the promoter. Moreover, the wild type TGIF effectively represses transcription when bound to its cognate DNA-binding site via its homeodomain. Deletion analysis revealed the presence of at least two separable repression domains within TGIF. Repression by one of these is dependent on the activity of histone deacetylases (HDACs), whereas the other appears not to require HDAC activity. Finally, we demonstrate that TGIF interacts with HDACs via its carboxyl-terminal repression domain. Together, these results suggest that TGIF is a multifunctional transcriptional repressor, which acts in part by recruiting HDAC activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601270     DOI: 10.1074/jbc.274.52.37105

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  Tgif1 represses apolipoprotein gene expression in liver.

Authors:  Tiffany A Melhuish; David D Chung; Glen A Bjerke; David Wotton
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

3.  A novel Gli3 enhancer controls the Gli3 spatiotemporal expression pattern through a TALE homeodomain protein binding site.

Authors:  Sarah Coy; Jorge H Caamaño; Jaime Carvajal; Michael L Cleary; Anne-Gaëlle Borycki
Journal:  Mol Cell Biol       Date:  2011-01-24       Impact factor: 4.272

4.  Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.

Authors:  Glen A Bjerke; Cathy Hyman-Walsh; David Wotton
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

5.  MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation.

Authors:  Zhongping Xu; Sabarinathan Ramachandran; Muthukumar Gunasekaran; Fangyu Zhou; Elbert Trulock; Daniel Kreisel; Ramsey Hachem; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2015-03-27       Impact factor: 10.247

6.  Defective T-cell activation is associated with augmented transforming growth factor Beta sensitivity in mice with mutations in the Sno gene.

Authors:  S Pearson-White; M McDuffie
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

7.  Hierarchical model of gene regulation by transforming growth factor beta.

Authors:  Yaw-Ching Yang; Ester Piek; Jiri Zavadil; Dan Liang; Donglu Xie; Joerg Heyer; Paul Pavlidis; Raju Kucherlapati; Anita B Roberts; Erwin P Böttinger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

8.  Regulation of folate receptor 1 gene expression in the visceral endoderm.

Authors:  J Michael Salbaum; Richard H Finnell; Claudia Kappen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

9.  Tiul1 and TGIF are Involved in Downregulation of TGFbeta1-induced IgA Isotype Expression.

Authors:  Kyoung-Hoon Park; Eun-Hee Nam; Goo-Young Seo; Su Ryeon Seo; Pyeung-Hyeun Kim
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

10.  Overlapping and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2 during mouse development.

Authors:  Jeffrey D Hildebrand; Philippe Soriano
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.